The intramembrane proteases signal peptide peptidase-like 2a and 2b have distinct functions In vivo

Molecular and Cellular Biology

Volumn 34, Issue 8, 2014, Pages 1398-1411

  Schneppenheim, Janna ^a   Hüttl, Susann ^a   Mentrup, Torben ^a   Lüllmann Rauch, Renate ^a   Rothaug, Michelle ^a   Engelke, Michael ^b   Dittmann, Kai ^b   Dressel, Ralf ^b   Araki, Masatake ^c   Araki, Kimi ^c   Wienands, Jürgen ^b   Fluhrer, Regina ^d,e   Saftig, Paul ^a   Schröder, Bernd ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c KUMAMOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF MUNICH   (Germany)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; IMMUNOGLOBULIN; PROTEINASE; SIGNAL PEPTIDE PEPTIDASE LIKE 2A; SIGNAL PEPTIDE PEPTIDASE LIKE 2B; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; INVARIANT CHAIN; MEMBRANE PROTEIN; SIGNAL PEPTIDE PEPTIDASE; SPPL2A PROTEIN, MOUSE; SPPL2B PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MATURATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; DENSITY GRADIENT CENTRIFUGATION; FEMALE; FLOW CYTOMETRY; HELA CELL; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; ANIMAL; BRAIN; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ASPARTIC ACID ENDOPEPTIDASES; B-LYMPHOCYTES; BRAIN; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROTEOLYSIS;

EID: 84896520931     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00038-14     Document Type: Article

References (44)

1. Lichtenthaler SF, Haass C, Steiner H. 2011. Regulated intramembrane proteolysis: lessons from amyloid precursor protein processing. J. Neurochem. 117:779-796. http://dx.doi.org/10.1111/j.1471-4159.2011.07248.x.
2. Urban S, Freeman M. 2002. Intramembrane proteolysis controls diverse signalling pathways throughout evolution. Curr. Opin. Genet. Dev. 12: 512-518. http://dx.doi.org/10.1016/S0959-437X(02)00334-9.
3. Voss M, Schröder B, Fluhrer R. 2013. Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases. Biochim. Biophys. Acta 1828:2828-2839. http://dx.doi.org/10.1016/j.bbamem.2013.03.033.
4. Schneppenheim J, Dressel R, Hüttl S, Lüllmann-Rauch R, Engelke M, Dittmann K, Wienands J, Eskelinen EL, Hermans-Borgmeyer I, Fluhrer R, Saftig P, Schröder B. 2013. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain. J. Exp. Med. 210:41-58. http://dx.doi.org/10.1084/jem.20121069.
5. Beisner DR, Langerak P, Parker AE, Dahlberg C, Otero FJ, Sutton SE, Poirot L, Barnes W, Young MA, Niessen S, Wiltshire T, Bodendorf U, Martoglio B, Cravatt B, Cooke MP. 2013. The intramembrane protease Sppl2a is required for B cell andDCdevelopment and survival via cleavage of the invariant chain. J. Exp. Med. 210:23-30. http://dx.doi.org/10.1084/jem.20121072.
6. Bergmann H, Yabas M, Short A, Miosge L, Barthel N, Teh CE, Roots CM, Bull-Jeelall KRY, Horikawa K, Whittle B, Balakishnan B, Sjollema G, Bertram EM, MacKay F, Rimmer AJ, Cornall RJ, Field MA, Andrews TD, Goodnow CC, Enders A. 2013. B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A. J. Exp. Med. 210:31-40. http://dx.doi.org/10.1084/jem.20121076.
7. Neefjes J, Jongsma ML, Paul P, Bakke O. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11:823-836. http://dx.doi.org/10.1038/nri3084.
8. Becker-Herman S, Arie G, Medvedovsky H, Kerem A, Shachar I. 2005. CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol. Biol. Cell 16:5061-5069. http://dx.doi.org/10.1091/mbc. E05-04-0327.
9. Friedmann E, Hauben E, Maylandt K, Schleeger S, Vreugde S, Lichtenthaler SF, Kuhn PH, Stauffer D, Rovelli G, Martoglio B. 2006. SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production. Nat. Cell Biol. 8:843-848. http://dx.doi.org/10.1038/ncb1440.
10. Fluhrer R, Grammer G, Israel L, Condron MM, Haffner C, Friedmann E, Bohland C, Imhof A, Martoglio B, Teplow DB, Haass C. 2006. A gamma-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b. Nat. Cell Biol. 8:894-896. http://dx.doi.org/10.1038/ncb1450.
11. Kirkin V, Cahuzac N, Guardiola-Serrano F, Huault S, Luckerath K, Friedmann E, Novac N, Wels WS, Martoglio B, Hueber AO, Zornig M. 2007. The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T cells. Cell Death. Differ. 14:1678-1687. http://dx.doi.org/10.1038/sj.cdd.4402175.
12. Martin L, Fluhrer R, Reiss K, Kremmer E, Saftig P, Haass C. 2008. Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J. Biol. Chem. 283:1644-1652. http://dx.doi.org/10.1074/jbc. M706661200.
13. Zahn C, Kaup M, Fluhrer R, Fuchs H. 2013. The transferrin receptor-1 membrane stub undergoes intramembrane proteolysis by signal peptide peptidase-like 2b. FEBS J. 280:1653-1663. http://dx.doi.org/10.1111/febs.12176.
14. Matza D, Kerem A, Shachar I. 2003. Invariant chain, a chain of command. Trends Immunol. 24:264-268. http://dx.doi.org/10.1016/S1471-4906(03)00073-5.
15. Golde TE, Wolfe MS, Greenbaum DC. 2009. Signal peptide peptidases: a family of intramembrane-cleaving proteases that cleave type 2 transmembrane proteins. Semin. Cell Dev. Biol. 20:225-230. http://dx.doi.org/10.1016/j.semcdb.2009.02.003.
16. Reference deleted.
17. Behnke J, Schneppenheim J, Koch-Nolte F, Haag F, Saftig P, Schröder B. 2011. Signal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late endosomes by a tyrosine motif in its C-terminal tail. FEBS Lett. 585:2951-2957. http://dx.doi.org/10.1016/j.febslet.2011.08.043.
18. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R. 2003. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197:1467-1476. http://dx.doi.org/10.1084/jem.20030286.
19. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R. 2006. CD44 is the signaling component of the macrophage migration inhibitory factor- CD74 receptor complex. Immunity 25:595-606. http://dx.doi.org/10.1016/j.immuni.2006.08.020.
20. Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, Bucala R, Weber C, Bernhagen J. 2009. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 583:2749-2757. http://dx.doi.org/10.1016/j.febslet.2009.07.058.
21. Calandra T, Roger T. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3:791-800. http://dx.doi.org/10.1038/nri1200.
22. Gore Y, Starlets D, Maharshak N, Becker-Herman S, Kaneyuki U, Leng L, Bucala R, Shachar I. 2008. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283:2784-2792. http://dx.doi.org/10.1074/jbc. M703265200.
23. Sapoznikov A, Pewzner-Jung Y, Kalchenko V, Krauthgamer R, Shachar I, Jung S. 2008. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat. Immunol. 9:388-395. http://dx.doi.org/10.1038/ni1571.
24. Araki K, Imaizumi T, Sekimoto T, Yoshinobu K, Yoshimuta J, Akizuki M, Miura K, Araki M, Yamamura K. 1999. Exchangeable gene trap using the Cre/mutated lox system. Cell Mol. Biol. 45:737-750.
25. Taniwaki T, Haruna K, Nakamura H, Sekimoto T, Oike Y, Imaizumi T, Saito F, Muta M, Soejima Y, Utoh A, Nakagata N, Araki M, Yamamura K, Araki K. 2005. Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. Dev. Growth Differ. 47: 163-172. http://dx.doi.org/10.1111/j.1440-169X.2005.00792.x.
26. Savalas LR, Gasnier B, Damme M, Lubke T, Wrocklage C, Debacker C, Jezegou A, Reinheckel T, Hasilik A, Saftig P, Schröder B. 2011. Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L. Biochem. J. 439: 113-128. http://dx.doi.org/10.1042/BJ20110166.
27. Kim KJ, Kanellopoulos-Langevin C, Merwin RM, Sachs DH, Asofsky R. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549-554.
28. Schröder B, Wrocklage C, Hasilik A, Saftig P. 2010. Molecular characterisation of "transmembrane protein 192" (TMEM192), a novel protein of the lysosomal membrane. Biol. Chem. 391:695-704. http://dx.doi.org/10.1515/BC.2010.062.
29. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. http://dx.doi.org/10.1038/227680a0.
30. Schagger H. 2006. Tricine-SDS-PAGE. Nat. Protoc. 1:16-22. http://dx.doi.org/10.1038/nprot.2006.4.
31. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92. http://dx.doi.org/10.1016/S0022-1759(98)00204-X.
32. Barois N, Forquet F, Davoust J. 1997. Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation. J. Biol. Chem. 272:3641-3647. http://dx.doi.org/10.1074/jbc.272.6.3641.
33. Radons J, Faber V, Buhrmester H, Volker W, Horejsi V, Hasilik A. 1992. Stimulation of the biosynthesis of lactosamine repeats in glycoproteins in differentiating U937 cells and its suppression in the presence of NH4Cl. Eur. J. Cell Biol. 57:184-192.
34. von Figura K. 1977. Human α-N-acetylglucosaminidase. 1. Purification and properties. Eur. J. Biochem. 80:523-533.
35. Friedmann E, Lemberg MK, Weihofen A, Dev Dengler KKU, Rovelli G, Martoglio B. 2004. Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J. Biol. Chem. 279:50790-50798. http://dx.doi.org/10.1074/jbc. M407898200.
36. Wubbolts R, Fernandez-Borja M, Oomen L, Verwoerd D, Janssen H, Calafat J, Tulp A, Dusseljee S, Neefjes J. 1996. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J. Cell Biol. 135:611-622. http://dx.doi.org/10.1083/jcb.135.3.611.
37. Sannerud R, Annaert W. 2009. Trafficking, a key player in regulated intramembrane proteolysis. Semin. Cell Dev. Biol. 20:183-190. http://dx.doi.org/10.1016/j.semcdb.2008.11.004.
38. Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. 2010. Transmembrane TNF-alpha: structure, function and interaction with anti- TNF agents. Rheumatology (Oxford) 49:1215-1228. http://dx.doi.org/10.1093/rheumatology/keq031.
39. Tsachaki M, Ghiso J, Efthimiopoulos S. 2008. BRI2 as a central protein involved in neurodegeneration. Biotechnol. J. 3:1548-1554. http://dx.doi.org/10.1002/biot.200800247.
40. Krawitz P, Haffner C, Fluhrer R, Steiner H, Schmid B, Haass C. 2005. Differential localization and identification of a critical aspartate suggest non-redundant proteolytic functions of the presenilin homologues SPPL2b and SPPL3. J. Biol. Chem. 280:39515-39523. http://dx.doi.org/10.1074/jbc. M501645200.
41. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J, Esselmann H, De SB. 2006. Presenilin clinical mutations can affect gamma- secretase activity by different mechanisms. J. Neurochem. 96:732-742. http://dx.doi.org/10.1111/j.1471-4159.2005.03578.x.
42. Lai MT, Chen E, Crouthamel MC, Muzio-Mower J, Xu M, Huang Q, Price E, Register RB, Shi XP, Donoviel DB, Bernstein A, Hazuda D, Gardell SJ, Li YM. 2003. Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. J. Biol. Chem. 278:22475-22481. http://dx.doi.org/10.1074/jbc. M300974200.
43. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. 1997. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89:629-639. http://dx.doi.org/10.1016/S0092-8674(00)80244-5.
44. Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L, Umans L, Schrijvers V, Checler F, Vanderstichele H, Baekelandt V, Dressel R, Cupers P, Huylebroeck D, Zwijsen A, Van Leuven F, De Strooper B. 1999. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. U. S. A. 96:11872-11877. http://dx.doi.org/10.1073/pnas.96.21.11872.